
An assortment of pharmaceutical pills (representative file photo). Specific recalled product: see recall details below. Photo: Michael Nutt / Wikimedia Commons (CC BY-SA 2.0).
Recall Database
Drug & Medication Defects Recalls
This hub groups 361 records where the problem is a drug or medication defect — potency out of spec, a dosage or labeling error, a stability or dissolution failure, or a mix-up that puts the wrong strength in the package. Most are FDA drug records (337), with 24 CPSC records that involve a drug or medication product.
A drug defect is not always about the pill itself; a failed child-resistant closure or a mislabeled carton lands here too. If you take a prescription or over-the-counter medication that has been recalled, this is one of two hubs to check — the other is Drug & Medical Product Contamination, which covers impurity and sterility problems.
The notices span 2023–2026, heaviest in 2026. Every row links to the FDA or CPSC notice with the lot numbers and the recall reason.
How this hub is built. This page groups the 361 recall records that 411 Press classifies as Drug & Medication Defects. Each record gets one primary hazard from a fixed, published rule set (taxonomy version 2026-07-28.C2.2 — this stamp marks when the classification rules last changed, not how current the recall data is; data currency is stated below). A record can carry secondary hazard tags but appears on only one hub. Regulators in this hub: FDA (337), CPSC (24). These notices were published 2023–2026. This is not an all-time archive — it is the current dataset, drawn from CPSC, FDA, and NHTSA notices and refreshed as new notices are ingested from the agency feeds, so it grows over time. A note on counting. This hub counts RECORDS, not recall events. The agencies package recalls differently — NHTSA issues one record per safety campaign, the CPSC one per recall, the FDA one per affected product line — so an FDA-heavy hub carries more product-line records per underlying recall than a CPSC or NHTSA one. Records here are grouped by hazard; the brand hubs, which rank companies, count by event instead. Every row links to the original agency notice. The agency's record is the authority; the hazard grouping is ours. For a small number of records the agency feed's own hazard text did not pass our integrity check; those rows read "See the agency notice for the hazard description" and link straight to the source, rather than show a summary we can't stand behind.
2026 (272)
- FDAClass II
Azelaic Acid Gel
CGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received.
- FDAClass II
Dorzolamide HCl and Timolol Maleate Ophthalmic Solution
Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops.
- FDAClass III
Lidolog Kit
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
- FDAClass II
Rohto Cooling Eye Drops Optic Glow (naphazoline hydrochloride 0.03%, povidone 0.5%, propylene glycol 0.2%)
Lack of Assurance of Sterility
- FDAClass II
Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 80 0.2%)
Lack of Assurance of Sterility
- FDAClass II
Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 90, 0.2%)
Lack of Assurance of Sterility
- FDAClass II
Rohto Cooling Eye Drops Dry Aid (povidone 0.68%, propylene glycol 0.3%)
Lack of Assurance of Sterility
- FDAClass II
Rohto Cooling Eye Drops Dry Aid (povidone 0.68%, propylene glycol 0.3%)
Lack of Assurance of Sterility
- FDAClass II
Rohto Cooling Eye Drops Digi Eye (hypromellose 0.35%, tetrahydrozoline HCl 0.05%)
Lack of Assurance of Sterility
- FDAClass II
Rohto Cooling Eye Drops Cool Relief (naphazoline hydrochloride 0.012%, polysorbate 80 0.2%)
Lack of Assurance of Sterility
- FDAClass II
Rohto Cooling Eye Drops ALL-IN-ONE (hypromellose 0.2%, tetrahydrozoline HCL 0.05%, zinc sulfate 0.25%)
Lack of Assurance of Sterility
- FDAClass II
Rising
Presence of Precipitate: medication was crystallizing and particles floating in the bottle
- FDAClass II
Levothyroxine Sodium Tablets
Subpotent Drug
- FDAClass II
Levothyroxine Sodium Tablets
Subpotent Drug
- FDAClass II
Levothyroxine Sodium Tablets
Subpotent Drug
- FDAClass II
Levothyroxine Sodium Tablets
Subpotent Drug
- FDAClass II
Levothyroxine Sodium Tablets
Subpotent Drug
- FDAClass II
Levothyroxine Sodium Tablets
Subpotent Drug
- FDAClass II
Levothyroxine Sodium Tablets
Subpotent Drug
- FDAClass II
Levothyroxine Sodium Tablets
Subpotent Drug
- FDAClass II
Levothyroxine Sodium Tablets
Subpotent Drug
- FDAClass II
Levothyroxine Sodium Tablets
Subpotent Drug
- FDAClass II
Levothyroxine Sodium Tablets
Subpotent Drug
- FDAClass II
Levothyroxine Sodium Tablets
Subpotent Drug
- FDAClass II
BD ChloraPrep Clear
Lack of Assurance of Sterility: Affected product may exhibit an open or incomplete seal on the packaging of the applicator
- FDAClass II
CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL)
Lack of Assurance of Sterility
- CPSCCritical
CVS Health Medicated Hemorrhoidal Wipes
The recalled medicated wipes contain lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The packaging of the wipes is not child-resistant, posing a risk of serious injury or death from poisoning if the contents of the wipes are ingested by young children.
- FDAClass II
Dextroamphetamine Saccharate
Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
- FDAClass II
TopCare Health
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
- FDAClass II
QC Quality Choice, Carbamide Peroxide, 6.5%, 0.5 FL
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
- FDAClass II
meijer, Carbamide Peroxide 6.5%, 0.5 FL OZ (15 mL), Washer Bulb included, NDC 41250-835-33, DIST
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
- FDAClass II
LEADER
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
- FDAClass II
GOOD NEIGHBOR PHARMACY
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
- FDAClass II
Foster & Thrive
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
- FDAClass II
FAMILY Wellness
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
- FDAClass II
CVS Health
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
- FDAClass II
Clinere, Carbamide Peroxide, a) 2 bottles of Clinere Carbamide Peroxide (2 x 0.50 mL) 6.5%, 0.5 fl
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
- FDAClass II
CAREone
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
- FDAClass II
AUDIOLOGIST'S CHOICE
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
- FDAClass II
Pemetrexed for Injection 500mg/Vial
Lack of Sterility Assurance
- FDAClass II
Pemetrexed for Injection 100mg/Vial
Lack of Sterility Assurance
- FDAClass II
Bortezomib for Injection 3.5mg/Vial
Lack of Sterility Assurance
- FDAClass II
Azacitidine for Injection 100mg/Vial
Lack of Sterility Assurance
- FDAClass II
Nystatin Cream USP
Subpotent Drug: Low out of specification assay results performed during long-term stability testing.
- FDAClass II
Glucagon Emergency Kit for Low Blood Sugar
CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
- FDAClass II
Perampanel CIII Tablets
Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.
- FDAClass II
Carton Label: MAJOR
Subpotent Drug
- FDAClass II
Synjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets)
CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a different product.
- FDAClass II
ChloraPrep FREPP
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
- FDAClass II
BD PurPrep
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
- FDAClass II
BD ChloraPrep Scrub Teal
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
- FDAClass II
BD ChloraPrep Scrub Teal
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
- FDAClass II
BD ChloraPrep Hi-Lite Orange
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
- FDAClass II
BD ChloraPrep Hi-Lite Orange
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
- FDAClass II
BD ChloraPrep Hi-Lite Orange
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
- FDAClass II
BD ChloraPrep CLear
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
- FDAClass II
BD ChloraPrep CLear
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
- FDAClass II
BD ChloraPrep Clear
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to customers outside of the intended distribution channel
- FDAClass II
IMULDOSA
Lack of assurance of Sterility:
- FDAClass II
Lidocaine HCl Injection USP
Lack of Assurance of Sterility
- FDAClass II
Accucaine
Lack of Assurance of Sterility
- FDAClass II
Levothyroxine Sodium Tablets
Subpotent Drug
- FDAClass II
Povi-One
sub potency
- FDAClass II
Sensipar (cinacalcet) Tablets
CGMP Deviations
- FDAClass II
Sensipar (cinacalcet) Tablets
CGMP Deviations
- FDAClass II
Sensipar (cinacalcet) Tablets
CGMP Deviations
- FDAClass II
Rapidol
CGMP Deviations; deficiencies observed during FDA inspection
- FDAClass II
Med Pride
CGMP Deviations; deficiencies observed during FDA inspection
- FDAClass II
Med Pride
CGMP Deviations; deficiencies observed during FDA inspection
- FDAClass II
Med Pride, HYDROCORTISONE CREAM 1%, Net Wt
CGMP Deviations; deficiencies observed during FDA inspection
- FDAClass II
Med Pride, HYDROCORTISONE CREAM 1%, Net Wt
CGMP Deviations; deficiencies observed during FDA inspection
- FDAClass II
Med Pride, 1% Clotrimazole Antifungal Cream, Net Wt
CGMP Deviations; deficiencies observed during FDA inspection
- FDAClass II
Med Pride
CGMP Deviations; deficiencies observed during FDA inspection
- FDAClass II
Med Pride
CGMP Deviations; deficiencies observed during FDA inspection
- FDAClass II
Med Pride
CGMP Deviations; deficiencies observed during FDA inspection
- FDAClass II
Lucky Super Soft
CGMP Deviations; deficiencies observed during FDA inspection
- FDAClass II
Lucky Super Soft, Antifungal Athlete's Foot Cream, Clotrimazole 1% Cream, Net Wt
CGMP Deviations; deficiencies observed during FDA inspection
- FDAClass II
Lil Drug Store
CGMP Deviations; deficiencies observed during FDA inspection
- FDAClass II
Cura Hongos
CGMP Deviations; deficiencies observed during FDA inspection
- FDAClass II
Circle K
CGMP Deviations; deficiencies observed during FDA inspection
- FDAClass III
Focalin XR (dexmethylphenidate HCl) 5 mg
Labeling: Incorrect or Missing Lot and/or Exp Date
- FDAClass II
Gasco Isopropyl Alcohol 70%, 32 oz (946 mL) Gasco Industrial Corp., PO Box 1360, Gurabo PR 00778, UPC 7 87302 12363 6
Subpotent drug
- FDAClass II
Gasco Isopropyl Alcohol 70%
Subpotent drug
- FDAClass II
Gasco Isopropyl Alcohol 70%, Net Contents: 16 Oz
Subpotent drug
- FDAClass II
Drogueria San Juan Puerto Rico Isopropyl Alcohol 70%
Subpotent drug
- FDAClass II
Drogueria San Juan Puerto Rico Isopropyl Alcohol 70%
Subpotent drug
- FDAClass II
Drogueria San Juan Puerto Rico Isopropyl Alcohol 70%
Subpotent drug
- FDAClass I
BD ChloraPrep FREPP Clear
Non-Sterility: Due to presence of Aspergillus penicillioides. And Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.
- FDAClass II
BD ChloraPrep FREPP Clear
Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.
- FDAClass II
BD ChloraPrep Clear
Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.
- FDAClass I
BD ChloraPrep Clear (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA))
Non-Sterility: Due to presence of Aspergillus penicillioides.
- FDAClass II
Fenofibrate Capsules
CGMP Deviations
- FDAClass III
Roast beef and cheddar closed face sandwich packed in clear plastic wrap with a green adhesive label
Incorrect Product Label; Roast Beef and Swiss closed face sub sandwich labeled as Turkey and Cheddar closed face sub sandwich
- FDAClass II
Xyvona (levorphanol tartrate tablets)
Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona
- FDAClass II
Xyvona (levorphanol tartrate tablets)
Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona
- FDAClass II
safco SensiCaine-Ultra (20% Benzocaine), Topical Anesthetic Gel, Strawberry Flavor, 1 oz
Defective container:may contain bottles with incomplete seals
- FDAClass II
Quala Dental Products
Defective container:may contain bottles with incomplete seals
- FDAClass II
PureLife
Defective container:may contain bottles with incomplete seals
- FDAClass II
Pearson Quality Topical Anesthetic Gel (20% Benzocaine)
Defective container:may contain bottles with incomplete seals
- FDAClass II
DHP Topical Anesthetic Gel, Benzocaine 20%, Strawberry Flavor, 1 oz
Defective container:may contain bottles with incomplete seals
- FDAClass II
Dental City TOPICAL ANESTHETIC GEL
Defective container:may contain bottles with incomplete seals
- FDAClass II
Burkhart topical anesthetic gel
Defective container:may contain bottles with incomplete seals
- FDAClass II
Clomiphene Citrate USP Active Pharmaceutical Ingredient (CAS : 50-41-9)
cGMP deviations
- FDAClass II
PReye Vitamin See Antioxidant Preservative Free Eye Drops, Distributed by: PReye, LLC, Golden, CO
Lack of Assurance of Sterility
- FDAClass II
Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC
Subpotent Drug
- FDAClass III
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
- FDAClass III
PRED MILD
Failed Stability Specifications
- FDAClass II
Great Value Hawaiian Roll 4pk, Item # F63384
Firm observed oily and sticky substance on direct food contact surface packaging of finished product.
- FDAClass II
Lidocaine HCl Injection USP
Lack of Assurance of Sterility
- FDAClass II
fentaNYL Citrate
Subpotent Drug
- FDAClass II
Estradiol Gel
Defective Container; packets were found to be either empty or partially full.
- FDAClass II
Gas-X, Simethicone 125 mg/ ANTIGAS, 120 SoftGels, Distributed by: Haleon, Warren, NJ 07059, UPC: 3 00674 35041 9
Labeling: Not Elsewhere Classified- Incomplete inactive ingredient information on the carton labeling.
- FDAClass II
cimzia (certolizumab pegol)
Lack of Assurance of Sterility
- FDAClass II
My Wife's Slaw Jalapeno Heat, packaged in 8 oz
Product was manufactured and distributed without the benefit of an approved food establishment inspection and the required regulatory safety parameters could not be verified.
- FDAClass II
My Wife's Slaw, packaged in 8 oz
Product was manufactured and distributed without the benefit of an approved food establishment inspection and the required regulatory safety parameters could not be verified.
- FDAClass II
Atomoxetine Capsules HCL
Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule.
- CPSCWarning
Travel Size Afrin® Original Nasal Spray 6 mL Bottles
The 6 mL nasal sprays contain an imidazoline, which must be in child-resistant packaging or meet the labeling requirements for non-complying packaging, as required by the Poison Prevention Packaging Act. The 6 mL nasal spray's packaging is not child-resistant nor bears the required labeling statement, posing a risk of serious injury or illness from poisoning, if the contents are swallowed by young children.
- FDAClass II
Oasis Tears PF
Lack of Assurance of Sterility: The recall is being initiated out of an abundance of caution following FDA observations noted during a recent inspection of Excelvision.
- FDAClass II
Octreotide Acetate for Injectable Suspension
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
- FDAClass II
Similasan
Lack of Assurance of Sterility: This recall has been initiated due to CGMP deviations found by the FDA during an inspection of the manufacturer.
- FDAClass II
iVIZIA
Lack of Assurance of Sterility: This recall has been initiated due to CGMP deviations found by the FDA during an inspection of the manufacturer.
- FDAClass II
Systane
Lack of Assurance of Sterility: Due to FDA inspection observations that it believes may impact product quality.
- FDAClass II
GenTeal Tears
Lack of Assurance of Sterility: Due to FDA inspection observations that it believes may impact product quality.
- FDAClass II
Optase Dry Eye Intense Drops (Glycerin 0.2%)
Lack of Assurance of Sterility
- FDAClass II
FRESHKOTE LUBRICANT EYEDROPS, Sterile, 0.33 FL OZ (10mL), Harrow Eye LLC, Nashville, TN USA
Lack of Assurance of Sterility
- FDAClass III
Levocarnitine Injection
Labeling: Missing Label
- FDAClass III
Premier
Labeling: Incorrect or Missing Lot and/or Exp Date:The expiration date has an extra digit and is printed as 2709114 instead of the correct 270914 (2027-09-14). It is important to note that this error is limited to the vial itself; the saleable unit of the box of 12 bottles has the correct expiration date printed.
- FDAClass III
busPIRone Hydrochloride Tablets
Subpotent drug
- FDAClass II
Omega-3-Acid
Failed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells.
- CPSCCritical
Various Brands of Iron-Containing Dietary Supplements
The dietary supplements contain iron, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the supplements is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
- FDAClass II
vite20 Antifungal Cream
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
- FDAClass II
TRIPENICOL S Antifungal Solution (Undecylenic Acid 25%)
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
- FDAClass II
TERPENICOL Antifungal Solution
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
- FDAClass II
TERPENICOL Antifungal Cream (Undecylenic Acid 13%)
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
- FDAClass II
Fungal Fusion ERADICATION Solution, Antifungal & Antimicrobial Kit
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
- FDAClass II
Desmopressin Nasal Spray
Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
- FDAClass III
Lidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2%)
Failed PH Specifications
- FDAClass II
Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose Bottles, Distr
This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.
- FDAClass II
DELFLEX
Lack of Assurance of Sterility: Potential leaks from perforations in bags.
- FDAClass II
DELFLEX
Lack of Assurance of Sterility: Potential leaks from perforations in bags.
- FDAClass II
Lidocaine HCl Injection
Lack of Assurance of Sterility
- FDAClass II
Lidocaine HCl injection
Lack of Assurance of Sterility
- FDAClass II
Bupivacaine Hydrochloride 0.75% in 8.25% Dextrose Injection
Lack of Assurance of Sterility
- FDAClass II
0.9% Sodium Chloride Injection
Lack of Assurance of Sterility
- FDAClass II
Sterile Water for Injection USP, 3000 mL bags, Rx only, Pharmacy Bulk Package, B
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
- FDAClass II
LACTATED RINGER'S IRRIGATION, 3000 mL bags, Sterile, Ex only, B
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
- FDAClass II
DEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
- FDAClass II
0.9 % SODIUM CHLORIDE IRRIGATION, USP, 3000 mL bags, Rx only, Sterile, B
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
- CPSCCritical
TecFlox Hair and Beard Growth Serum Bottles
The hair and beard growth serum contains minoxidil, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The bottles are not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
- CPSCCritical
Tuymec Minoxidil Hair Growth Kits, 5% Minoxidil with Biotin Spray
The hair serum contains minoxidil, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The hair serum's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
- FDAClass II
Phenylephrine Hydrochloride Injectable Solution, 40mg, 250*mL Bag, wells pharma of Houston, NDC 73702-122-03
cGMP deviations.
- FDAClass II
Ketamine Hydrochloride Injectable Solution
cGMP deviations.
- FDAClass II
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15
cGMP deviations.
- FDAClass II
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride
cGMP deviations.
- FDAClass II
fentaNYL Citrate injectable Solution in 0.9% Sodium Chloride
cGMP deviations.
- FDAClass II
fentaNYL Citrate Injectable Solution
cGMP deviations.
- FDAClass II
fentaNYL Citrate Injectable Solution
cGMP deviations.
- FDAClass II
Label is predominantly green with white lettering in a clear plastic clamshell container
mislabeled Coconut Date Bites. (product is coconut covered, label is for regular date bites)
- FDAClass II
EPINEPHRINE Injection, USP, 1 mg/10mL (0.1 mg/mL), Rx only, INTERNATIONAL MEDICATION SYSTEMS, LIMITED, So
Lack of Assurance of Sterility
- FDAClass II
Blemish Spot Treatment (Salicylic Acid) 1%
Failed Stability Specifications
- FDAClass III
Magnesium Chloride
Subpotent drug
- FDAClass II
Fluocinonide
Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
- FDAClass II
Fluocinonide
Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
- FDAClass II
Fluocinonide
Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
- FDAClass II
Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%)
Lack of Assurance of Sterility
- FDAClass II
Discount Drug Mart Food Market
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
- FDAClass II
Discount Drug Mart Food Market
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
- FDAClass II
Vancomycin HCL, 1 gram added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
- FDAClass II
Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
- FDAClass II
Vancomycin HCI, 1.25 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
- FDAClass II
norepinephrine Bitartrate, 32mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
- FDAClass II
norepinephrine Bitartrate,16mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St
Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
- FDAClass II
Clonidine Transdermal System
CGMP Deviations: use of an unapproved raw material
- FDAClass II
Clonidine Transdermal System
CGMP Deviations: use of an unapproved raw material
- FDAClass II
Clonidine Transdermal System
CGMP Deviations: use of an unapproved raw material
- FDAClass III
Skin Rehab, Calming Skin Gel, Hydrocortisone Balm, hydrocortisone 1%, .53oz net wt
Subpotent Drug
- FDAClass III
Remedy Gel, hydrocortisone 1%, 30 mL/ 1 fl oz per bottle, Distributed By: glo Skin Beauty, Denver, CO 80216
Subpotent Drug
- FDAClass III
Essential Calming Skin Gel, hydrocortisone 1%, 120mL/4oz net wt
Subpotent Drug
- FDAClass II
Octreotide Acetate for Injectable Suspension
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
- FDAClass II
Octreotide Acetate for Injectable Suspension
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
- FDAClass II
Octreotide Acetate for Injectable Suspension
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
- FDAClass II
CUROSURF (poractant alfa)
Lack of Assurance of Sterility
- FDAClass III
POPPING BOBA RTD STRAWBERRY DRAGON F/OOLONG TEA 12 X 13.8OZ
Packaging integrity issue that may compromise product quality .
- FDAClass III
POPPING BOBA RTD PEACH OOLONG TEA 12 X 13.8OZ
Packaging integrity issue that may compromise product quality .
- FDAClass III
POPPING BOBA RTD MIXED BERRY HIBISCUS TEA 12 X 13.8OZ
Packaging integrity issue that may compromise product quality .
- FDAClass III
POPPING BOBA RTD MANGO PASSION FRUIT GREEN TEA 12 X 13.8OZ
Packaging integrity issue that may compromise product quality .
- FDAClass II
Meclizine Hydrochloride Tablets
Failed tablet specifications.
- FDAClass II
Lanreotide Injection
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.
- FDAClass II
Lanreotide Injection
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.
- FDAClass II
5% Dextrose Injection
Lack of Assurance of Sterility
- FDAClass II
5% Dextrose Injection
Lack of Assurance of Sterility
- FDAClass II
5% Dextrose Injection
Lack of Assurance of Sterility
- FDAClass II
0.9% Sodium Chloride Injection
Lack of Assurance of Sterility
- FDAClass II
0.9% Sodium Chloride Injection
Lack of Assurance of Sterility
- FDAClass II
0.9% Sodium Chloride Injection
Lack of Assurance of Sterility
- FDAClass II
0.9% Sodium Chloride Injection
Lack of Assurance of Sterility
- FDAClass II
0.9% Sodium Chloride Injection
Lack of Assurance of Sterility
- FDAClass II
0.9% Sodium Chloride Injection
Lack of Assurance of Sterility
- FDAClass II
0.9% Sodium Chloride Injection
Lack of Assurance of Sterility
- FDAClass II
0.9% Sodium Chloride Injection
Lack of Assurance of Sterility
- FDAClass II
0.9% Sodium Chloride Injection
Lack of Assurance of Sterility
- FDAClass II
0.9% Sodium Chloride Injection
Lack of Assurance of Sterility
- FDAClass II
0.45% Sodium Chloride Injection
Lack of Assurance of Sterility
- FDAClass II
Semaglutide-Glycine-Cyanocobalamin Injectable
Lack of Assurance of Sterility
- FDAClass II
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only, Sterile, Apotex Corp
Lack of Assurance of Sterility
- CPSCCritical
Tomum Hair Regrowth Treatment with Minoxidil for Men and Women Spray Bottles
The hair serum contains minoxidil, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The hair serum's bottles are not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
- FDAClass II
Ultra Lubricating Eye Drops (polyethylene 400 0.4%, propylene glycol 0.3%)
Lack of Assurance of Sterility
- FDAClass II
STERILE EYE DROPS SOOTHING TEARS (polyethylene glycol 400 0.4% and propylene glycol 0.3%)
Lack of Assurance of Sterility
- FDAClass II
Sterile EYE DROPS REDNESS LUBRICANT (glycerin 0.25% and naphazoline HCl 0.012%)
Lack of Assurance of Sterility
- FDAClass II
Sterile Eye Drops ORIGINAL FORMULA (tetrahydrozoline HCl 0.05%)
Lack of Assurance of Sterility
- FDAClass II
Sterile EYE DROPS AC (tetrahydrozoline HCl 0.05%, zinc sulfate 0.25%), 0.5 fl
Lack of Assurance of Sterility
- FDAClass II
EYE DROPS Advanced Relief
Lack of Assurance of Sterility
- FDAClass II
Dry Eye Relief Eye Drops
Lack of Assurance of Sterility
- FDAClass II
Artificial Tears Sterile Lubricant Eye Drops (polyvinyl alcohol 0.5%, povidone 0.6%)
Lack of Assurance of Sterility
- FDAClass II
Tirzepatide Inj
Lack of Assurance of Sterility
- FDAClass II
Tirzepatide Inj
Lack of Assurance of Sterility
- FDAClass II
Semaglutide Inj
Lack of Assurance of Sterility
- FDAClass II
Semaglutide Inj
Lack of Assurance of Sterility
- FDAClass II
Levothyroxine Sodium Tablets USP 150 mcg
Subpotent Drug
- FDAClass III
C2O Coconut Water with Pulp (17.5 oz) 15 Pack UPC: 8-50274-00792-8
The outer cardboard box for the canned coconut water has the incorrect Nutrition Facts Panel and Ingredient List, which does not include added sugar (5g per 17.5oz can), while the primary packaging (the can) has the correct Nutrition Facts Panel and Ingredient List.
- FDAClass III
Gelatin Capsule Pack for use with the Sodium Iodide I-131 Kit
Failed Tablet/Capsule Specifications
- FDAClass II
MAXIMUM
Stability Data Does Not Support Expiry Date.
- FDAClass II
MAXIMUM, ZONE 1, 4% Lidocaine Cream, 1/2 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-014
Stability Data Does Not Support Expiry Date.
- FDAClass II
FIVE-STAR
Stability Data Does Not Support Expiry Date.
- FDAClass III
Nilotinib Capsules
Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
- FDAClass III
Nilotinib Capsules
Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
- FDAClass II
Midodrine Hydrochloride Tablets
Defective container; inadequately sealed blister packaging.
- FDAClass III
Eptifibatide Injection
Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing. The approved statement is 75 mg/100 mL vial for weight-adjusted infusion.
- FDAClass I
Product label reads in part as "WHITE VEIN ADVANCED ALKALOIDS CHEWABLE TABLETS 225mg 7-Hydroxymitragynine per container
A sample of the product revealed the active ingredient is in a quantity greater than the labeled specification.
- FDAClass II
Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd
Defective Delivery System: Missing or duplicated needles within the injection kit
- FDAClass II
vancomycin HCl
Lack of Assurance of Sterility
- FDAClass II
vancomycin HCl
Lack of Assurance of Sterility
- FDAClass II
thiamine HCl
Lack of Assurance of Sterility
- FDAClass II
ketamine HCl
Lack of Assurance of Sterility
- FDAClass II
acyclovir sodium
Lack of Assurance of Sterility
- FDAClass II
Pro Numb Tattoo Numbing Spray
cGMP deviations
- FDAClass II
Pro Numb Tattoo Numbing Spray
cGMP deviations
- CPSCCritical
Viofairy Hair Growth Serum
The serum bottles contain minoxidil, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The serum's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
- CPSCCritical
Sefudun Hair Growth Serum Kits
The hair growth serum contains minoxidil, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The serum bottle is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
- CPSCCritical
Ultimate Multivitamin+ Dietary Supplement Bottles
The bottles are filled with dietary supplements containing iron, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
- FDAClass II
Diclofenac Sodium, Topical Gel, 3%, 100 g tube, Rx only, Mfd
Failed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.
- CPSCCritical
Iristar Minoxidil Spray Bottles
The recalled spray bottles contain minoxidil, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
- FDAClass II
WP WipesPlus Hand Sanitizing Wipes (Benzalkonium Chloride 0.13%), 5x7, 100 CT, Progressive Products, 211 S
CGMP Deviations
- FDAClass II
Wipes Plus
CGMP Deviations
- FDAClass II
Savannah Antibacterial Towelettes (Benzalkonium Chloride 0.13%), 1 towelette, 4 x 7, R&R Enterprise, NDC 59647-749-02
CGMP Deviations
- FDAClass II
Medi-First Antiseptic Wipes (BZK)(Benzalkonium Chloride 0.13%)
CGMP Deviations
- FDAClass II
Med-Nap Cleansing Towelettes (Benzalkonium Chloride 0.13%)
CGMP Deviations
- FDAClass II
Med Nap BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%)
CGMP Deviations
- FDAClass II
Max Packaging Antibacterial Towelette (Benzalkonium Chloride 0.13%)
CGMP Deviations
- FDAClass II
Hand Sanitizing Wipes (Benzalkonium Chloride 0.13%)
CGMP Deviations
- FDAClass II
Green Guard Antiseptic Wipes (Benzalkonium Chloride 0.13%), 25 wipes per box, Distributed by Green Guard, St
CGMP Deviations
- FDAClass II
First Aid Only BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%), 50 Wipes, NDC 0924-7116-03
CGMP Deviations
- FDAClass II
First Aid Only BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%) 100 Wipes, NDC 0924-7116-04
CGMP Deviations
- FDAClass II
First Aid Only BZK Antiseptic Towelette (Benzalkonium Chloride 0.13%)
CGMP Deviations
- FDAClass II
Dynarex Obstetrical Towelettes Cleanser (Benzalkonium Chloride 0.13%)
CGMP Deviations
- FDAClass II
Dynarex
CGMP Deviations
- FDAClass II
Dynarex
CGMP Deviations
- FDAClass II
Dukal BZK Antiseptic Towelette (Benzalkonium Chloride 0.13%) 1000 Packs per case
CGMP Deviations
- FDAClass II
Cleansing Towelette (Benzalkonium Chloride 0.13%)
CGMP Deviations
- FDAClass II
Children's Healthcare of Atlanta
CGMP Deviations
- FDAClass II
BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%)
CGMP Deviations
- FDAClass II
Antimicrobial Alcohol Hand Wipe
CGMP Deviations
- FDAClass II
1) BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%) 5"x7" Piedmont Sanitizing Hand Wipes
CGMP Deviations
- FDAClass II
Thyroid
Subpotent Drug
- FDAClass II
methylprednisolone tablets
Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.
- CPSCCritical
Ruahouine Hair Growth Serum Bottles
The serum bottles contain minoxidil, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The serum's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
- CPSCCritical
RootStim Beard Growth Serum, 5% Minoxidil
The beard growth serum contains minoxidil, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The serum's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
- FDAClass II
spicely ORGANIC sumac NO ARTIFICIAL COLORING NO GLUTEN - NO MSG - NO SOY NO PRESERVATIVES - NO WHEAT NO SUGAR - NO SALT
Product contains salt and is mislabeled
- FDAClass II
spicely ORGANIC garlic salt NO ARTIFICIAL COLORING NO GLUTEN - NO MSG - NO SOY NO PRESERVATIVES - NO WHEAT NO SUGAR
Product contains salt and is mislabeled
- FDAClass II
spicely ORGANIC celery salt NO ARTIFICIAL COLORING NO GLUTEN - NO MSG - NO SOY NO PRESERVATIVES - NO WHEAT NO SUGAR
Product contains salt and is mislabeled
- FDAClass II
Oxycodone Hydrochloride Tablets
Defective container: card seal defects (weak/non-existent seals), leading to the tablets falling out of their cavities.
- FDAClass II
AQ 120 GFEW, Aquarion Preserved Cartridges (2) 3.7 Gallons each
cGMP deviations.
2025 (87)
- FDAClass II
Vista Tears Polyethylene Glycol 400 0.4% w/v
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
- FDAClass II
Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced Dry Eye Relief Revitalizing Formula
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
- FDAClass II
Vista Gonio Eye Lubricant, Hypromellose Ophthalmic Solution USP
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
- FDAClass II
Vista Gel Hypromellose USP 0.3% w/v, Eye Drops Dry Eye Relief Lubricating Gel, 10 ml
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
- FDAClass II
CHNaO Fluorescein Sodium Ophthalmic Strips
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
- FDAClass II
BioGlo Fluorescein Sodium Ophthalmic Strips USP, 100 diagnostic strips, Manufactured by Omni Lens PVT
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
- FDAClass II
Bio Glo Fluorescein Sodium Ophthalmic Strips USP
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
- FDAClass II
Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt
Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules
- FDAClass II
Ondansetron Orally Disintegrating Tablets
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
- FDAClass III
parodontax (cetylpyridinium chloride)ACTIVE GUM HEALTH, Mouthwash, Mint
Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for missing or illegible lot and expiration date coding on the bottles.
- FDAClass I
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt
CGMP Deviations: product found to contain lead.
- FDAClass III
Diclofenac Sodium Topical Gel
Failed PH Specifications
- FDAClass III
traZODONE Hydrochloride Tablets
Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.
- FDAClass II
INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone)
Failed Disintegration Specifications: above the time expected.
- CPSCCritical
Mamisan Pain Relieving Topical Ointment
The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
- CPSCCritical
Feel The Beard Minoxidil Beard Growth Oil for Men
The beard serum contains minoxidil, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The hair serum's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
- FDAClass II
Oxycodone and Acetaminophen CII Tablets USP
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
- FDAClass II
Oxycodone and Acetaminophen CII Tablets USP
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
- FDAClass II
ORL Kids Natural Toothpaste, Bubblegum Flavor, 4 oz (120ml), ORL Labs, LLC, Scottsdale, Arizona USA
cGMP Deviations
- FDAClass II
ORL Kids Mouthwash, Bubblegum Flavor, 16.9 oz
cGMP Deviations
- FDAClass III
Cisatracurium Besylate Injection USP
Subpotent product:out of specification assay results observed during long term stability testing.
- FDAClass III
Cisatracurium Besylate Injection USP
Subpotent product:out of specification assay results observed during long term stability testing.
- FDAClass III
Cisatracurium Besylate Injection USP
Subpotent product:out of specification assay results observed during long term stability testing.
- FDAClass II
Ondansetron ODT Tablets
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
- FDAClass III
Varenicline Tablets, 1mg, 56 Tablets, Rx only, Distributor: Dr
Sub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit.
- FDAClass III
Carton label: Testosterone Gel 1%
Defective Container - A defect in the side-seal which allows leakage of product.
- FDAClass II
Sertraline Hydrochloride Tablets USP
Defective container - seal not adhering to bottles
- FDAClass II
OraVerse
Defective container: cracked/broken cartridges
- FDAClass II
Lidocaine HCI 2% and Epinephrine 1:100
Defective container: cracked/broken cartridges
- FDAClass II
darby dental supply
Defective container: cracked/broken cartridges
- FDAClass II
Cook-Walte
Defective container: cracked/broken cartridges
- FDAClass II
Benco dental Graham CHEMICAL CO
Defective container: cracked/broken cartridges
- FDAClass II
3% Polocaine DENTAL
Defective container: cracked/broken cartridges
- FDAClass II
2% Xylocaine DENTAL with Epinephrine 1:100
Defective container: cracked/broken cartridges
- FDAClass II
Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only, Mfd
Failed Stability Specifications: Observed OOS results: eg results for colour index
- FDAClass II
WeCare, Zinc Oxide Ointment, Net Wt
cGMP deviations
- FDAClass II
Wecare Enema
cGMP deviations
- FDAClass II
Wecare Calasoothe, Net wt
cGMP deviations
- FDAClass II
Nivagen Pharmaceuticals, Zinc Oxide Ointment USP, Zinc Oxide 20% Skin Protectant, Net Wt
cGMP deviations
- FDAClass II
Nivagen, Zinc Oxide Ointment USP, Zinc Oxide 20 %, Net Wt
cGMP deviations
- FDAClass II
Nivagen, Zinc Oxide Ointment, Net Wt
cGMP deviations
- FDAClass II
Lanashield Skin Barrier, 4 oz
cGMP deviations
- FDAClass II
Globe Zinc Oxide Ointment USP Zinc Oxide 20% Skin Protectant, Net Wt
cGMP deviations
- FDAClass II
Globe Clotrimazole Cream USP, 1 % Antifungal Cream, Net Wt., 5 oz
cGMP deviations
- FDAClass II
Globe Clotrimazole Cream, USP, 1 %, Net Wt
cGMP deviations
- FDAClass II
Dynashield Skin Protectant, Net Wt
cGMP deviations
- FDAClass II
Dynashield
cGMP deviations
- FDAClass II
Dynagel, Moisturizing Wound Hydrogel, Net Wt
cGMP deviations
- FDAClass I
POTASSIUM CHLORIDE Inj
Labeling: Label Error on Declared Strength-The overwrap label may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq instead of POTASSIUM CHLORIDE Inj. 20 mEq
- FDAClass I
POTASSIUM CHLORIDE Inj
Labeling: Label Error on Declared Strength-The overwrap label may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq instead of POTASSIUM CHLORIDE Inj. 20 mEq
- FDAClass II
Lanthanum Carbonate chewable tablets
Failed stability specifications: Out of specification for hardness test
- FDAClass II
Lanthanum Carbonate chewable tablets
Failed stability specifications: Out of specification for hardness test
- FDAClass III
Klarity-C Drops (Cyclosporine) 0.1%
Subpotent Drug
- FDAClass II
Acetaminophen 500mg Caffeine 65mg caplets
Labeling: Label Mix-up. This issue affects the outer box labeling only. The box incorrectly states the ingredients Acetaminophen 500mg and Caffeine 65mg. The inner pouch correctly states the ingredients are Aspirin (NSAID)*500mg and Caffeine 32.5mg.
- FDAClass II
Tirzepatide Injection
Lack of Assurance of Sterility
- FDAClass II
Semaglutide Injection
Lack of Assurance of Sterility
- FDAClass II
Semaglutide Injection
Lack of Assurance of Sterility
- FDAClass II
Semaglutide Injection
Lack of Assurance of Sterility
- FDAClass II
Semaglutide Injection
Lack of Assurance of Sterility
- FDAClass II
Amoxicillin and Clavulanate Potassium for Oral Suspension USP
Subpotent drug; Clavulanate Potassium component
- FDAClass II
HADLIMA (adalimumab-bwwd) injection
Lack of Assurance of Sterility.
- FDAClass II
Haloperidol Lactate Injection
Labeling: Not Elsewhere Classified:Incorrect RFID tag labels applied to product by repackaging firm.
- FDAClass II
Sugared+Bronzed Tinted Mineral Sunscreen SPF 50, Zinc Oxide 21%, Net WT 3.3 OZ (93 G) per tube, Dist
CGMP Deviations
- FDAClass II
Sea Enzyme Ultra Umbrella Sunscreen SPF 30
CGMP Deviations
- FDAClass II
Karina Daily Moisturizer SPF 25, Octinoxate 7.5% and Zinc Oxide 7.0%, Net WT
CGMP Deviations
- FDAClass II
Gabriel Mineral Sunscreen SPF 50, Zinc Oxide 21%, 2.1 oz, Net 61 g per tube, Dist
CGMP Deviations
- FDAClass II
Elixir by Coco March Tinted Mineral Sunscreen SPF 50
CGMP Deviations
- FDAClass II
Elixir by Coco March Mineral Sunscreen SPF 50
CGMP Deviations
- FDAClass II
Dr
CGMP Deviations
- FDAClass II
Doctor
CGMP Deviations
- FDAClass II
Doctor D
CGMP Deviations
- FDAClass II
Doctor D
CGMP Deviations
- FDAClass II
Doctor D
CGMP Deviations
- FDAClass II
Doctor D
CGMP Deviations
- FDAClass II
Doctor D
CGMP Deviations
- FDAClass II
CLEARSTEM YOU ARE SUNSHINE SPF 50
CGMP Deviations
- CPSCCritical
Dissolved Oxygen Test Kits
The recalled test kits contain a bottle of sulfuric acid, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The test kits violate the mandatory standard for child-resistant packaging because the bottle of sulfuric acid is not child-resistant, posing a risk of serious injury or death from poisoning, if the contents are swallowed by young children.
- CPSCCritical
RELIEVE Numbing Cream
The numbing cream contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The numbing cream's packaging is not child-resistant, posing a risk of serious injury or death from poisoning, if the contents are swallowed by young children.
- FDAClass II
Fentanyl citrate
CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.
- FDAClass II
Phenylephrine HCI
CGMP Deviations
- FDAClass III
Espumil, Lipophilic foam base, 500 ml, 24G15-T02-115604
Labeling: Not Elsewhere Classified
- CPSCInfo
Bariatric Fusion Iron Multivitamin Bottles
The recalled multivitamins contain iron, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The recalled packaging of the iron-containing multivitamins violates the federal standard for child-resistant packaging because the bottle caps are not child-resistant, posing a risk of deadly poisoning, if the contents are swallowed by young children.
- CPSCCritical
Séfralls Minoxidil Hair Generation Serum
The hair serum contains minoxidil, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The hair serum's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
- CPSCInfo
California Gold Nutrition Iron Supplements: Daily Prenatal Multi, Ultamins Women's Multivitamin, and Ultamins Women's 50+ Multivitamin
The recalled dietary supplements contain iron, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The iron-containing dietary supplement packages violate the federal standard for child-resistant packaging because the bottles and blister packs are not child-resistant, posing a risk of deadly poisoning, if the contents are swallowed by young children.
- CPSCInfo
Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packs
The Safetussin over-the-counter cold medicine contains acetaminophen, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the products is not child-resistant as a tablet can be pushed through the foil, posing a risk of poisoning if the contents are swallowed by young children.
- CPSCInfo
NFH Iron SAP, NFH Heme Iron SAP and NFH Prenatal SAP bottles
The recalled dietary supplements contain iron, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act (PPPA). The packaging is not child-resistant, posing a risk of poisoning if the contents are swallowed by young children.
- CPSCInfo
Benadryl Liquid Elixir, 100 mL bottles
The Benadryl contains diphenhydramine, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the products is not child-resistant, posing a risk of poisoning if the contents are swallowed by young children.
2023 (2)
- CPSCInfo
Solaray Liposomal Multivitamins
The recalled dietary supplements contain iron, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child-resistant, posing a risk of poisoning if the contents are swallowed by young children.
- CPSCInfo
Ferrous Sulfate (Iron) Enteric-Coated Tablets, 324 mg - 100 Tablet Bottles
The recalled dietary supplements contain iron which must be in child-resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child-resistant, posing a risk of poisoning if the contents are swallowed by young children.